Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses

[1]  G. Hardingham,et al.  The Dichotomy of NMDA Receptor Signaling , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[2]  S. Lipton,et al.  S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[3]  N. Knuckey,et al.  Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury , 2007, Journal of neuroscience research.

[4]  S. Rhee,et al.  Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. , 2007, Kidney international. Supplement.

[5]  David S. Park,et al.  Role of Cdk5-Mediated Phosphorylation of Prx2 in MPTP Toxicity and Parkinson's Disease , 2007, Neuron.

[6]  Margaret A. Taylor,et al.  Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer’s disease patients and a transgenic Alzheimer’s disease mouse model , 2007, Molecular and Cellular Neuroscience.

[7]  C. Winterbourn,et al.  The High Reactivity of Peroxiredoxin 2 with H2O2 Is Not Reflected in Its Reaction with Other Oxidants and Thiol Reagents* , 2007, Journal of Biological Chemistry.

[8]  Ann Marie Craig,et al.  NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo , 2007, The Journal of Neuroscience.

[9]  Hilmar Bading,et al.  Decoding NMDA Receptor Signaling: Identification of Genomic Programs Specifying Neuronal Survival and Death , 2007, Neuron.

[10]  L. Netto,et al.  Reactions of yeast thioredoxin peroxidases I and II with hydrogen peroxide and peroxynitrite: rate constants by competitive kinetics. , 2007, Free radical biology & medicine.

[11]  Fred H. Gage,et al.  NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus , 2006, Nature.

[12]  J. Klose,et al.  Acute and long-term proteome changes induced by oxidative stress in the developing brain , 2006, Cell Death and Differentiation.

[13]  S. Lipton,et al.  The chemical biology of clinically tolerated NMDA receptor antagonists , 2006, Journal of neurochemistry.

[14]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[15]  Changlian Zhu,et al.  Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity , 2006, The European journal of neuroscience.

[16]  N. Hardingham,et al.  Preconditioning Doses of NMDA Promote Neuroprotection by Enhancing Neuronal Excitability , 2006, The Journal of Neuroscience.

[17]  K. Muir.  Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. , 2006, Current opinion in pharmacology.

[18]  H. Masutani,et al.  The Involvement of Thioredoxin and Thioredoxin Binding Protein‐2 on Cellular Proliferation and Aging Process , 2005, Annals of the New York Academy of Sciences.

[19]  P. Mecocci,et al.  Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  Dae-Yeul Yu,et al.  Characterization of neural cell types expressing peroxiredoxins in mouse brain , 2005, Neuroscience Letters.

[21]  A. Hannan,et al.  Nature, nurture and neurology: gene–environment interactions in neurodegenerative disease , 2005, The FEBS journal.

[22]  A. Shalev,et al.  Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. , 2005, Endocrinology.

[23]  N. Hardingham,et al.  Nuclear Ca2+ and the cAMP Response Element-Binding Protein Family Mediate a Late Phase of Activity-Dependent Neuroprotection , 2005, The Journal of Neuroscience.

[24]  Takahisa Taguchi,et al.  Diminished Neuronal Activity Increases Neuron-Neuron Connectivity Underlying Silent Synapse Formation and the Rapid Conversion of Silent to Functional Synapses , 2005, The Journal of Neuroscience.

[25]  G. McKenzie,et al.  Nuclear Ca2+ and CaM kinase IV specify hormonal‐ and Notch‐responsiveness , 2005, Journal of neurochemistry.

[26]  S. Rhee,et al.  Reduction of Cysteine Sulfinic Acid by Sulfiredoxin Is Specific to 2-Cys Peroxiredoxins* , 2005, Journal of Biological Chemistry.

[27]  S. Rhee,et al.  Characterization of Mammalian Sulfiredoxin and Its Reactivation of Hyperoxidized Peroxiredoxin through Reduction of Cysteine Sulfinic Acid in the Active Site to Cysteine* , 2004, Journal of Biological Chemistry.

[28]  R. Corriveau,et al.  Pronounced Cell Death in the Absence of NMDA Receptors in the Developing Somatosensory Thalamus , 2004, The Journal of Neuroscience.

[29]  Richard T. Lee,et al.  Hyperglycemia Promotes Oxidative Stress through Inhibition of Thioredoxin Function by Thioredoxin-interacting Protein* , 2004, Journal of Biological Chemistry.

[30]  I. Kohane,et al.  Gene regulation and DNA damage in the ageing human brain , 2004, Nature.

[31]  N. Plesnila,et al.  Combination Therapy in Ischemic Stroke: Synergistic Neuroprotective Effects of Memantine and Clenbuterol , 2004, Stroke.

[32]  Joachim Klose,et al.  Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice* , 2004, Journal of Biological Chemistry.

[33]  E. Koonin,et al.  Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.

[34]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Toledano,et al.  ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin , 2003, Nature.

[36]  P. Coffer,et al.  FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons , 2003, The Journal of cell biology.

[37]  S. Oikawa,et al.  Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo , 2003, Journal of neurochemistry.

[38]  G. Marfany,et al.  Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is underexpressed in Down syndrome fetal brains , 2003, Cellular and Molecular Life Sciences CMLS.

[39]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[40]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[41]  J. Olney,et al.  Drug‐induced Apoptotic Neurodegeneration in the Developing Brain , 2002, Brain pathology.

[42]  H. Bading,et al.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.

[43]  Kai Stühler,et al.  Genetic analysis of the mouse brain proteome , 2002, Nature Genetics.

[44]  Hilmar Bading,et al.  Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity , 2001, Nature Neuroscience.

[45]  C. Ikonomidou,et al.  Neuronal death enhanced by N-methyl-D-aspartate antagonists. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Zorumski,et al.  Neural activity and survival in the developing nervous system , 2000, Molecular Neurobiology.

[47]  C. Sommer,et al.  Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction 1 1 Published on the World Wide Web on 22 June 2000. , 2000, Brain Research.

[48]  P. Seeburg,et al.  C-Terminal Truncation of NR2A Subunits Impairs Synaptic But Not Extrasynaptic Localization of NMDA Receptors , 2000, The Journal of Neuroscience.

[49]  D. Accili,et al.  Differential regulation of gene expression by insulin and IGF‐1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR , 2000, The EMBO journal.

[50]  S. Lipton,et al.  Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. , 1999, European journal of pharmacology.

[51]  G. Westbrook,et al.  The Incorporation of NMDA Receptors with a Distinct Subunit Composition at Nascent Hippocampal Synapses In Vitro , 1999, The Journal of Neuroscience.

[52]  M. Dragunow,et al.  Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective , 1999, Nature Medicine.

[53]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[54]  M. Manns,et al.  Copyright © 1997, American Society for Microbiology CREB Controls LAP/C/EBP � Transcription , 1997 .

[55]  J. Inoue,et al.  MEK Kinase Is Involved in Tumor Necrosis Factor α-Induced NF-κB Activation and Degradation of IκB-α* , 1996, The Journal of Biological Chemistry.

[56]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[57]  M. Imagawa,et al.  DNA Binding Specificity of the CCAAT/Enhancer-binding Protein Transcription Factor Family (*) , 1996, The Journal of Biological Chemistry.

[58]  M. Olive,et al.  Design of a C/EBP-specific, Dominant-negative bZIP Protein with Both Inhibitory and Gain-of-function Properties * , 1996, The Journal of Biological Chemistry.

[59]  M E Greenberg,et al.  Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. , 1993, Science.

[60]  M E Greenberg,et al.  Stimulation of protein tyrosine phosphorylation by NMDA receptor activation , 1991, Science.

[61]  C. Rossberg,et al.  Neuroprotective effect of memantine demonstrated in vivo and in vitro. , 1990, European journal of pharmacology.

[62]  H. J. G. GUNDERSEN,et al.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[63]  A. Holmgren,et al.  Rat liver thioredoxin and thioredoxin reductase: purification and characterization. , 1982, Biochemistry.

[64]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[65]  Z. A. Wood,et al.  Structure, mechanism and regulation of peroxiredoxins. , 2003, Trends in biochemical sciences.

[66]  M. F. Sánchez-Fonta,et al.  Peroxiredoxin 2 ( PRDX 2 ) , an antioxidant enzyme , is under-expressed in Down syndrome fetal brains , 2003 .

[67]  M. Küçük,et al.  Reduction of Edema and Infarction by Memantine and MK-801 After Focal Cerebral Ischaemia and Reperfusion in Rat , 2000, Acta Neurochirurgica.

[68]  J. Olney,et al.  Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. , 1999, Science.

[69]  R. Dempsey,et al.  Protective Effects of Memantine Against Ischemia-Reperfusion Injury in Spontaneously Hypertensive Rats , 1999, Acta Neurochirurgica.

[70]  M. Manns,et al.  CREB Controls LAP/C/EBP b Transcription , 1997 .

[71]  W. Wesemann,et al.  Distribution of memantine in brain, liver, and blood of the rat. , 1982, Arzneimittel-Forschung.